Simona Radice

633 total citations
22 papers, 374 citations indexed

About

Simona Radice is a scholar working on Genetics, Immunology and Epidemiology. According to data from OpenAlex, Simona Radice has authored 22 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 9 papers in Immunology and 7 papers in Epidemiology. Recurrent topics in Simona Radice's work include Inflammatory Bowel Disease (15 papers), Microscopic Colitis (7 papers) and Biosimilars and Bioanalytical Methods (7 papers). Simona Radice is often cited by papers focused on Inflammatory Bowel Disease (15 papers), Microscopic Colitis (7 papers) and Biosimilars and Bioanalytical Methods (7 papers). Simona Radice collaborates with scholars based in Italy, France and United Kingdom. Simona Radice's co-authors include Gionata Fiorino, Silvio Danese, Daniela Gilardi, Federica Furfaro, Mariangela Allocca, Laurent Peyrin‐Biroulet, Alessandra Zilli, Camille Zallot, Ferdinando D’Amico and Antonino Spinelli and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Journal of Advanced Nursing.

In The Last Decade

Simona Radice

21 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simona Radice Italy	10	141	140	136	117	82	22	374
Natália Sousa Freitas Queiroz Brazil	12	56 0.4×	52 0.4×	143 1.1×	45 0.4×	104 1.3×	46	346
Ibrahim Alghamdi Saudi Arabia	8	108 0.8×	22 0.2×	30 0.2×	119 1.0×	34 0.4×	17	328
Andrew St. Martin United States	9	166 1.2×	149 1.1×	16 0.1×	196 1.7×	40 0.5×	27	517
Sue Morey Australia	13	30 0.2×	38 0.3×	70 0.5×	49 0.4×	52 0.6×	38	593
Patrick Whelan United States	10	90 0.6×	26 0.2×	17 0.1×	48 0.4×	38 0.5×	26	382
Emilio Monte‐Boquet Spain	9	52 0.4×	66 0.5×	49 0.4×	14 0.1×	73 0.9×	42	297
Ido Somekh Israel	11	84 0.6×	112 0.8×	56 0.4×	37 0.3×	37 0.5×	27	291
Erik H Vogelzang Netherlands	8	109 0.8×	110 0.8×	44 0.3×	16 0.1×	38 0.5×	20	338
Caitlin Baptiste United States	8	32 0.2×	59 0.4×	37 0.3×	130 1.1×	26 0.3×	23	422

Countries citing papers authored by Simona Radice

Since Specialization

Citations

This map shows the geographic impact of Simona Radice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simona Radice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simona Radice more than expected).

Fields of papers citing papers by Simona Radice

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simona Radice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simona Radice. The network helps show where Simona Radice may publish in the future.

Co-authorship network of co-authors of Simona Radice

This figure shows the co-authorship network connecting the top 25 collaborators of Simona Radice. A scholar is included among the top collaborators of Simona Radice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simona Radice. Simona Radice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

D’Amico, Ferdinando, Mariangela Allocca, Federica Furfaro, et al.. (2024). Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn's disease. Immunotherapy. 16(9). 581–595. 6 indexed citations

D’Amico, Ferdinando, Mariangela Allocca, Federica Furfaro, et al.. (2023). The Role of IL-23 Inhibitors in Crohn’s Disease. Journal of Clinical Medicine. 13(1). 224–224. 19 indexed citations

D’Amico, Ferdinando, Mariangela Allocca, Gionata Fiorino, et al.. (2023). Advances in pharmacotherapy for ulcerative colitis: a focus on JAK1 inhibitors. Expert Opinion on Pharmacotherapy. 24(7). 849–861. 8 indexed citations

Allocca, Mariangela, Simona Radice, Cristiana Bonifacio, et al.. (2022). P230 Ultrasonography-based and Magnetic Resonance-based Lémann Index: two sides of the same coin. Journal of Crohn s and Colitis. 16(Supplement_1). i278–i279. 1 indexed citations

Furfaro, Federica, Ferdinando D’Amico, Alessandra Zilli, et al.. (2022). Noninvasive Assessment of Postoperative Disease Recurrence in Crohn’s Disease: A Multicenter, Prospective Cohort Study on Behalf of the Italian Group for Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology. 21(12). 3143–3151. 18 indexed citations

Spagnuolo, Rocco, Daniele Napolitano, Elisa Schiavoni, et al.. (2021). Nursing‐sensitive outcomes in adult inflammatory bowel disease: A systematic review. Journal of Advanced Nursing. 77(5). 2248–2266. 7 indexed citations

Solitano, Virginia, Ferdinando D’Amico, Mariangela Allocca, et al.. (2021). Rediscovering histology: what is new in endoscopy for inflammatory bowel disease?. Therapeutic Advances in Gastroenterology. 14. 1088188668–1088188668. 10 indexed citations

Costantino, Andrea, Daniele Noviello, Francesco Conforti, et al.. (2021). COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients’ Association. Inflammatory Bowel Diseases. 28(3). 474–478. 22 indexed citations

Allocca, Mariangela, Gionata Fiorino, Camille Zallot, et al.. (2020). Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts. Clinical Gastroenterology and Hepatology. 18(9). 2134–2135. 92 indexed citations

10.

Furfaro, Federica, Lucine Vuitton, Gionata Fiorino, et al.. (2020). SFED recommendations for IBD endoscopy during COVID-19 pandemic: Italian and French experience. Nature Reviews Gastroenterology & Hepatology. 17(8). 507–516. 13 indexed citations

11.

Loy, Laura, Gionata Fiorino, Giulia Roda, et al.. (2020). New Paradigms to Help Decisions in Treatment Choice: Head to Head Trial of Biological Therapies in Inflammatory Bowel Diseases. Current Drug Targets. 22(4). 370–378. 1 indexed citations

12.

Fiorino, Gionata, Mariangela Allocca, Federica Furfaro, et al.. (2020). Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience. Journal of Crohn s and Colitis. 14(9). 1330–1333. 46 indexed citations

13.

Fiorino, Gionata, Daniela Gilardi, Simona Radice, et al.. (2020). Absence of COVID-19 Infection in Patients Accessing IBD Unit at Humanitas, Milan: Implications for Postlockdown Measures. The American Journal of Gastroenterology. 115(10). 1719–1721. 3 indexed citations

14.

D’Amico, Ferdinando, Lieven Pouillon, Marjorie Argollo, et al.. (2019). Multidisciplinary management of the nocebo effect in biosimilar-treated IBD patients: Results of a workshop from the NOCE-BIO consensus group. Digestive and Liver Disease. 52(2). 138–142. 26 indexed citations

15.

Pouillon, Lieven, Silvio Danese, Ailsa Hart, et al.. (2019). Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar‐treated IBD patients. Alimentary Pharmacology & Therapeutics. 49(9). 1181–1187. 42 indexed citations

16.

Fiorino, Gionata, M. Begoña Ruiz-Argüello, Daniel Nagore, et al.. (2018). Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 24(3). 601–606. 41 indexed citations

17.

Fiorino, Gionata, Simona Radice, Daniela Gilardi, et al.. (2017). P475 Switching from infliximab originator to CT-P13 is not related to increased immunogenicity in IBD patients: a prospective case-control study. Journal of Crohn s and Colitis. 11(suppl_1). S320–S320. 3 indexed citations

18.

Fiorino, Gionata, Daniel Nagore, Simona Radice, et al.. (2017). P633 Antibodies to infliximab in patients treated with either the reference biologic or the biosimilar CT-P13 show identical reactivity towards biosimilars CT-P13 and SB2 in inflammatory bowel disease. Journal of Crohn s and Colitis. 11(suppl_1). S403–S404. 4 indexed citations

19.

Fiorino, Gionata, Simona Radice, Daniela Gilardi, et al.. (2017). Switching from Infliximab Originator to CT-P13 is not Related to Increased Immunogenicity in IBD Patients: A Prospective Case-Control Study. Gastroenterology. 152(5). S384–S384. 3 indexed citations

20.

Fiorino, Gionata, Amagoia Ametzazurra, Daniel Nagore, et al.. (2017). P605 Rapid detection of anti-infliximab antibodies in inflammatory bowel disease patients treated with the reference biologic or the biosimilar CT-P13: performance comparison with ELISA. Journal of Crohn s and Colitis. 11(suppl_1). S388–S388. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact